XNAS: SMMT
Summit Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazo...
Read More
16.12
0.66
(4.27%)
2.7M
XNAS Volume
XNAS 13 Mar, 2026 4:08 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Summit Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..